Skip to main content

Your stock market edge

Ondine Biomedical (OBI), the Canadian life sciences company pioneering light-activated antimicrobial treatments, announced that its Steriwave® nasal photodisinfection is now available through the NHS Supply Chain, making it significantly easier for NHS hospitals in England and Wales to purchase. This marks the first time a light-activated antimicrobial has been available through the NHS Supply Chain, a national body which manages the sourcing, delivery and supply of healthcare products to the NHS and healthcare organizations in England and Wales.

Comment: Shares of OBI have maintained most of their post May gains, in the wake of the fundraise and increased revenues reported for 2023. The latest NHS Supply Chain news should be a trigger for fresh gains.

DG Innovate (DGI), the advanced research and development company developing pioneering solutions in sustainable mobility and energy storage, is pleased to announce the appointment of Rt Hon Sir Michael Fallon KCB as an independent Non-Executive director of the Company with immediate effect. DGI said it was delighted to welcome Sir Michael to the DG Innovate Board.  Sir Michael’s extensive government and private sector experience, particularly in relevant sectors to the Company, will be invaluable as we look to rapidly exploit the significant commercial potential in DG Innovate’s technology and the wider opportunity to use DG Innovate as a platform to build a larger company focused on the sector.

Comment: Just for a change we have a new face at DGI who is not ex-Tesla. That said, given that we are not in either the 19th or 20th centuries, having a posh, titled, Tory on the headed notepaper is not necessarily a plus, however capable that person may be.

Andrada Mining (ATM), the African technology metals mining company with a portfolio of mining and exploration assets in Namibia, hereby provides an unaudited operational update for the quarter ended 31 May 2024. Cash decreased from GBP17.5 million (USD22.2 million) at the end of February 2024 to GBP11.9 million (USD15.2 million) on 31 May 2024 mainly due to payments for the pre-concentration circuit project and increased volume of ore stockpiles in preparation for the expanded plant capacity. The conclusion of the BWL agreement will potentially provide GBP7.6 million (USD9.7 million) towards general working capital, ongoing exploration, metallurgy and study workstreams.

Comment: ATM is certainly showing us that it has been a busy company. But the process of getting from where it is to where it wants to be needs to be explained in order to get the stock out of its recent 4.5p – 5.5p range.

Caracal Gold (GCAT), the East African gold producer with over 1,300,000 oz JORC compliant gold resources, is pleased to provide an update and announce signature of a binding Heads of Terms to fund the Kilimapesa expansion project from a strategic investor. GCAT said it was very pleased to welcome Cynergy as strategic investors and as its partners. The investment from Cynergy is a great leap forward towards completion of the expansion of the Kilimapesa Gold Mine unlocking the value at Kilimapesa for all of stakeholders. Having a partner who is well funded, has vast experience and success in the region is great for Caracal and its plans to grow its business in the region.

Comment: It would appear that shareholders of GCAT have finally reached the Promised Land, and in a way that is probably rather better than they could have wished for. Indeed, the gold price is up significantly since the company has been fishing for a partner on Kilimapesa.